Biotech Showcase
THE INVESTOR CONFERENCE FOR INNOVATORS
January 13–15, 2025 | San Francisco, CAJanuary 21–22, 2025 | Virtual

Present at Seed Showcase

Seed Showcase provides investors and pharma companies to engage with the up-and-coming young companies. Up to 50 seed-stage companies will be chosen to give a 7-minute company presentation to investors, biopharma companies, and tech transfer offices.

Benefits of Presenting

  • ACCESS THE RIGHT AUDIENCE: Biotech Showcase and its family of events attract investors representing over USD 400 Billion in capital, and highly motivated strategic partners in the life science ecosystem. 36% of attendees are investors - don't miss your chance to stand in front of the right audience.
  • MORE ONE-TO-ONE MEETINGS: Based on previous events, presenting biotech companies have 15% more meetings than other attending biotech companies.

Presenting Options, Criteria and Fees

PLEASE NOTE
Company presenters need to apply first before registering for Biotech Showcase. Once approved, presenters will be sent special instructions to complete their registration.

In order to present and attend Seed Showcase you must meet the criteria and be approved at the discretion of the conference organizers. Submission of an application does not guarantee approval for the highly reduced registration rate.

Click here for information on the cancellation policy, payments, and sending a replacement.

All-Access Presentation

Fee Structure

All-Access Presentation

  • $1,625 - before September 27, 2024
  • $1,870 - before November 8, 2024
  • $2,120 - after November 8, 2024

Includes:

  • One registration for the presenter
  • A 7-minute in-person presentation in San Francisco

Your registration will also include the ability to request meetings with investors and other attendees using the partneringONE® software.

Criteria

To qualify for a Seed Showcase Registration your company must be:

  • A seed-stage company with total financing of USD 2 million or less (this includes dilutive and non-dilutive funding and grants)
  • Created in the last three years
  • Employing fewer than five people
  • Developing new therapeutic products, technology platforms, digital medicine, or medtech technologies

ENHANCED SUPPORT FOR ALL PRESENTING COMPANIES

Marketing:

We continue to enhance our marketing efforts for presenting companies. Activities include:

  • Promotional emails and posts on all media channels leading up to the conference.
  • Distribution of presenting company list to pharma and investors to support organizing meetings.

Media:

  • Embargoed News: Companies with important announcements are encouraged to embargo their news or press releases (provide copy ahead of distribution date), before and during the event. Presenting companies can confidentially share their news by sending an email including a press release or send a summary of announcement to our media team. Our team will share this news with media outlets and press attending the conference. All embargo dates will be strictly adhered to as indicated by the presenting company.
  • Press Releases: Press releases provided by presenting companies will be distributed to our network of investors, pharma and biotech execs via our social media channels.

  • Press Release Templates: A template to announce that the company has been selected to present and the date/time of the presentation will be provided to presenters.

Presenter Guidelines:

The presenter guidelines include tips and tricks on how to perfect your presentation as well as important dates and the length of your presentation. 

View presenter guidelines >>

QUESTIONS?

About a presentation slot?

Lawrence Joseph

Demy-Colton

+1 646-895-0981

ljoseph@demy-colton.com

About submitting a request to present?

Lila Taylor

Demy-Colton

+1 831 588 8594

ltaylor@demy-colton.com

For all other questions please contact conferences@ebdgroup.com.